JP2013523749A5 - - Google Patents

Download PDF

Info

Publication number
JP2013523749A5
JP2013523749A5 JP2013502740A JP2013502740A JP2013523749A5 JP 2013523749 A5 JP2013523749 A5 JP 2013523749A5 JP 2013502740 A JP2013502740 A JP 2013502740A JP 2013502740 A JP2013502740 A JP 2013502740A JP 2013523749 A5 JP2013523749 A5 JP 2013523749A5
Authority
JP
Japan
Prior art keywords
quinolin
phenyl
hydroxy
hydroxythieno
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013502740A
Other languages
English (en)
Japanese (ja)
Other versions
JP5849302B2 (ja
JP2013523749A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/030278 external-priority patent/WO2011123419A1/en
Publication of JP2013523749A publication Critical patent/JP2013523749A/ja
Publication of JP2013523749A5 publication Critical patent/JP2013523749A5/ja
Application granted granted Critical
Publication of JP5849302B2 publication Critical patent/JP5849302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013502740A 2010-03-29 2011-03-29 三環化合物およびこれを含有するpbk阻害剤 Active JP5849302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31860610P 2010-03-29 2010-03-29
US61/318,606 2010-03-29
PCT/US2011/030278 WO2011123419A1 (en) 2010-03-29 2011-03-29 Trycyclic compounds and pbk inhibitors containing the same

Publications (3)

Publication Number Publication Date
JP2013523749A JP2013523749A (ja) 2013-06-17
JP2013523749A5 true JP2013523749A5 (enExample) 2014-05-15
JP5849302B2 JP5849302B2 (ja) 2016-01-27

Family

ID=44712585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013502740A Active JP5849302B2 (ja) 2010-03-29 2011-03-29 三環化合物およびこれを含有するpbk阻害剤

Country Status (15)

Country Link
US (2) US8962648B2 (enExample)
EP (1) EP2552206B1 (enExample)
JP (1) JP5849302B2 (enExample)
KR (1) KR101757502B1 (enExample)
CN (1) CN102917590B (enExample)
AU (1) AU2011235319B2 (enExample)
BR (1) BR112012023836B1 (enExample)
CA (1) CA2792941C (enExample)
DK (1) DK2552206T3 (enExample)
ES (1) ES2547571T3 (enExample)
IL (1) IL222080B (enExample)
MX (1) MX2012011412A (enExample)
SG (1) SG184376A1 (enExample)
TW (1) TWI503323B (enExample)
WO (1) WO2011123419A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201990240A1 (ru) * 2013-12-24 2019-06-28 Бристол-Маерс Сквибб Компани Новые трициклические соединения в качестве противораковых средств
TWI557011B (zh) 2015-05-25 2016-11-11 可影像處理的自行車錶裝置
EP3307725A1 (en) 2015-06-11 2018-04-18 Basilea Pharmaceutica International AG Efflux-pump inhibitors and therapeutic uses thereof
GB201617758D0 (en) 2016-10-20 2016-12-07 Almac Discovery Limited Pharmaceutical compounds
CN108341774B (zh) * 2017-01-25 2022-07-19 首药控股(北京)股份有限公司 取代的喹啉酮类抑制剂
BR112019021136A2 (pt) 2017-04-10 2020-07-21 Bayer Aktiengesellschaft n-ariletil-2-arilquinolina-4-carboxamidas substituídas e uso das mesmas
US12024715B2 (en) 2017-11-07 2024-07-02 Temple University-Of The Commonwealth System Of Higher Education Compositions and methods for improved T cells
CN111099941B (zh) * 2018-10-26 2022-10-18 中国科学院上海有机化学研究所 一种烷基腈类化合物的制备方法
TW202300150A (zh) * 2021-03-18 2023-01-01 美商薛定諤公司 環狀化合物及其使用方法
CN117362304A (zh) * 2022-07-07 2024-01-09 深圳微芯生物科技股份有限公司 一种甲酰胺取代的杂三环类衍生物、其制备方法及其应用
WO2024097228A1 (en) * 2022-10-31 2024-05-10 Meliora Therapeutics, Inc. Compounds targeting cdk11 and methods of using the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377096A (en) * 1976-12-17 1978-07-08 Teijin Ltd Preparation of thieno 2,3-c quinolin-4(5h)-one-7-acetic acids
FR2636063B1 (fr) * 1988-09-05 1993-04-30 Centre Nat Rech Scient Composes phenylpyrroliques utiles en tant que medicaments, leur preparation et leur application
DE19806348A1 (de) * 1998-02-12 1999-08-19 Schering Ag 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln
US6506769B2 (en) 1999-10-06 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
US6638929B2 (en) * 1999-12-29 2003-10-28 Wyeth Tricyclic protein kinase inhibitors
ATE353320T1 (de) * 1999-12-29 2007-02-15 Wyeth Corp Tricyclische proteinkinasehemmer
DE10242106A1 (de) 2002-09-11 2004-04-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Phosphorgruppenhaltige Carbonsäurederivate mit organisch polymerisierbaren Gruppen
KR20050057404A (ko) 2002-09-17 2005-06-16 워너-램버트 캄파니 엘엘씨 정신분열증 치료용 헤테로환 치환된 피페라진
WO2004035577A2 (en) * 2002-10-16 2004-04-29 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
GB0501999D0 (en) * 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
PT2061765E (pt) * 2006-09-01 2015-02-06 Senhwa Biosciences Inc Moduladores de serina-treonina-proteína-quinase e de parp
WO2009010804A1 (en) * 2007-07-19 2009-01-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Macrocyclic compounds as antiviral agents
AU2009219154A1 (en) * 2008-02-29 2009-09-03 Cylene Pharmaceuticals, Inc. Protein kinase modulators

Similar Documents

Publication Publication Date Title
JP2013523749A5 (enExample)
JP6831450B2 (ja) Gpr119アゴニストとしてのチアゾロピリジン誘導体
ES2441196T3 (es) Derivado de anillo condensado nitrogenado, composiciones farmacéuticas que lo contienen, y su uso con fines médicos
DK2614061T3 (en) Quinoline and quinoxaline derivatives as kinase inhibitors
ES2638850T3 (es) Compuestos de azabenzimidazol como inhibidores de las isoenzimas de la PDE4 para el tratamiento de trastornos del SNC y otros trastornos
KR20020063934A (ko) 코르티코트로핀 방출 인자 길항제
CN103313987A (zh) 吡唑并吡啶化合物、吡唑并吡啶化合物以及它们作为tyk2抑制剂的用途
KR101757502B1 (ko) 트리시클릭 화합물 및 이를 함유하는 pbk 저해제
TWI839524B (zh) 抑制jak激酶1的新型化合物
KR20120124428A (ko) 치환된 피롤로-아미노피리미딘 화합물
EP1463507A1 (en) Thienopyrimidine compounds as protein tyrosine kinase inhibitors
TW201927757A (zh) 作為parp14抑制劑之喹唑啉酮
CN113754679B (zh) 取代的嘧啶二酮类化合物及其用途
CN114206853A (zh) 用于治疗的parp14的靶向蛋白质降解
CN101027305A (zh) 稠合杂环型激酶抑制剂
TW202039446A (zh) 雜環化合物
JP7774573B2 (ja) トリアゾロン化合物
EP2825537B1 (en) Dihydropyridopyrimidine and dihydronaphthyridine derivatives as tyrosine kinase inhibitors of especially vegf and pdgf
EP2825166A1 (en) Method of treating ophthalmic conditions with kinase inhibitors
WO2024175998A1 (en) Benzenesulfonamide derivatives and uses thereof
WO2023126951A1 (en) Inhibitors of autophagy-related protein-protein interactions
CN118515653A (zh) 一种ezh2特异性抑制剂及其制备方法和用途
HK1187274A (en) Azabenzothiazole compounds, compositions and methods of use